Assuming early is required, the following results were found.

  • Pregnancy & MS - Considerations before starting a family

    I was 26 years old and newly married. I was working full time and had just started graduate school. I remember wondering early on in my diagnosis if I would ever be able to have a child. Some of the things that ran through my mind were: Could I have a...

    https://mschristian.org/index.php/blog/pregnancy-ms-considerations-before-starting-a-family
  • AAN recommends people 65+ be screened yearly for memory problems

    it because such problems are not severe enough to affect their daily activities. Yet mild cognitive impairment can be an early sign of Alzheimer's disease or other forms of dementia. It can also be a symptom of sleep problems, medical illness,...

    https://mschristian.org/index.php/blog/aan-recommends-people-65-be-screened-yearly-for-memory-problems
  • Multiple sclerosis treatments delay progression of the disease

    An international study finds multiple sclerosis treatments have long-term benefits, and that early treatment is important. The Royal Melbourne Hospital and University of Melbourne-led study is the first to provide evidence that the currently available...

    https://mschristian.org/index.php/blog/multiple-sclerosis-treatments-delay-progression-of-the-disease
  • Atara Biotherapeutics Announces Third Quarter 2019 Financial Results and Recent Clinical, Operational and Strategic Progress - BioSpace

    the randomized, double-blind, placebo-controlled Phase 1b part of this study. “We are encouraged by the safety profile and early findings of potential efficacy for people living with progressive MS, as shown in our Phase 1a study data presented at...

    https://mschristian.org/index.php/blog/atara-biotherapeutics-announces-third-quarter-2019-financial-results-and-recent-clinical-operational-and-strategic-progress-biospace
  • What causes numbness and tingling?

    after the nerve pressure is reduced or relieved. Multiple sclerosis Numbness and tingling are two of the most common and early symptoms of MS. MS often causes mild to severe numbness and tingling on the skin or certain parts of the body, including the:...

    https://mschristian.org/index.php/blog/what-causes-numbness-and-tingling
  • CorTechs Labs Enters Phase 2 of $1.15 Million NIH Grant to Automate the Diagnosis and Prediction of Alzheimer's Disease - Business Wire

    states that Alzheimer's is a progressivedisease, where dementia symptoms gradually worsen over a number of years. In its early stages, memory loss is mild, but with late-stage Alzheimer's, individuals lose the ability to carry on a conversation and...

    https://mschristian.org/index.php/blog/cortechs-labs-enters-phase-2-of-1-15-million-nih-grant-to-automate-the-diagnosis-and-prediction-of-alzheimer-s-disease-business-wire
  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    annual relapse rates, disability progression, treatment resistance, and health-related quality of life. Use from the start Early intervention is key. “We really have a window of opportunity,” Kobelt said. “The disease starts even before we can see...

    https://mschristian.org/index.php/blog/ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • Biogen Strengthens MS & SMA Portfolio as Competition Lurks - Yahoo Finance

    targeting the myostatin pathway for potential muscle enhancement across a range of neuromuscular diseases including SMA. In early 2019, Biogen signed a new collaboration with Skyhawk Therapeutics to develop an oral splicing modulator for multiple...

    https://mschristian.org/index.php/blog/biogen-strengthens-ms-sma-portfolio-as-competition-lurks-yahoo-finance
  • Early effective treatment may protect from cognitive decline in paediatric multiple sclerosis - MD Linx

    Early effective treatment may protect from cognitive decline in paediatric multiple sclerosis MD Linx Because cognitive impairment (CI) is a critical characteristic in patients with childhood or juvenile multiple sclerosis (MS), researchers encouraged...

    https://mschristian.org/index.php/blog/early-effective-treatment-may-protect-from-cognitive-decline-in-paediatric-multiple-sclerosis-md-linx
  • #ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds

    treatment up to the first trimester of pregnancy, and 0.10 in those continuing beyond this period. Researchers believe that early treatment resumption was important to lessen the risk of relapses in the group of women who continued Tysabri treatment...

    https://mschristian.org/index.php/blog/ectrims2019-tysabri-during-pregnancy-and-after-delivery-seems-safe-reduces-relapse-risk-study-finds
  • Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

    from Phase II results.Novartis plans to initiate submissions to health authorities by end of 2019. “It is clear that early initiation of highly effective treatment for MS improves long-term outcomes, and there is a high need for potent, safe, and...

    https://mschristian.org/index.php/blog/novartis-ofatumumab-demonstrates-superiority-versus-aubagio-in-two-head-to-head-phase-iii-multiple-sclerosis-studies
  • Economic Factors Amplify Burden of Disease for Patients With Multiple Sclerosis

    This underscores the report’s recommendation of aiming to alter the disease course through lifestyle measures and early treatment with disease-modifying therapy. "The time to intervene is obviously at the beginning," Dr. Kobelt stressed. "We are not...

    https://mschristian.org/index.php/blog/economic-factors-amplify-burden-of-disease-for-patients-with-multiple-sclerosis
  • What to know about MS fatigue

    characteristic of MS. Lassitude differs from other kinds of fatigue because it tends to: be more severe occur daily develop early in the morning, even after a restful night get worse throughout the day come on suddenly get worse with heat and humidity...

    https://mschristian.org/index.php/blog/what-to-know-about-ms-fatigue
  • Vision Quest - The New York Times

    Advertisement Voices How going temporarily blind led me to see my life more clearly. Erik WinkowskiCredit By Evan Cooper Oct. 8, 2019, 5:00 a.m. ET Early one summer morning, I was awakened by a hammering on the inside of my skull. It felt as if a...

    https://mschristian.org/index.php/blog/vision-quest-the-new-york-times
  • A Cheap Biotech Stock Tests a Novel Treatment for Multiple Sclerosis - Barron's

    Atara Biotherapeutics has an out-of-favor stock and a novel treatment for multiple sclerosis that’s in early clinical trials. At an international meeting of MS doctors on Friday, researchers reported that Atara’s therapy showed hints of actually...

    https://mschristian.org/index.php/blog/a-cheap-biotech-stock-tests-a-novel-treatment-for-multiple-sclerosis-barron-s
  • How does MS affect the eyes?

    affect a person's vision and the treatment options for these symptoms. MS and eye problems Vision problems are a potential early sign of MS. Multiple sclerosis (MS) is a progressive disease in which the immune system mistakenly attacks healthy nerve...

    https://mschristian.org/index.php/blog/how-does-ms-affect-the-eyes-1
  • Biogen scores FDA nod for Tecfidera follow-up Vumerity as MS threats linger

    Biogen's multiple sclerosis business has been treading water and its best-selling med, Tecfidera, might just run up against early generics. But now, the company has its next launch—and, it hopes, Tecfidera replacement—in the newly FDA-approved MS med...

    https://mschristian.org/index.php/blog/biogen-scores-fda-nod-for-tecfidera-follow-up-vumerity-as-ms-threats-linger
  • How new gene discoveries could guide precision medicine in multiple sclerosis

    groups in MS are studying the role of genes and their variants in the progression and potential treatment of the disease. Early this year, a team at the University of Chicago found that a derivative of the hypertension drug Wytensin selectively inhibits...

    https://mschristian.org/index.php/blog/how-new-gene-discoveries-could-guide-precision-medicine-in-multiple-sclerosis
  • Rethinking neurodegenerative disease treatment: Target multiple pathological proteins

    Nearly all major neurodegenerative diseases -- from Alzheimer's to Parkinson's -- are defined and diagnosed by the presence of one of four proteins that have gone rogue: tau, amyloid-beta (Aβ), alpha-synuclein (α-syn), or TDP-43. As such,...

    https://mschristian.org/index.php/blog/rethinking-neurodegenerative-disease-treatment-target-multiple-pathological-proteins
  • A molecular key for delaying the progression of Multiple Sclerosis is found

    or preventing its cells from accessing the central nervous system and damaging it. These therapies are effective in the early phases of the disease, but they do not prevent its advance and the progressive functional deterioration. During the progressive...

    https://mschristian.org/index.php/blog/a-molecular-key-for-delaying-the-progression-of-multiple-sclerosis-is-found

Results 1 - 20 of 51
 
 

Follow Us on Twitter

Follow Us On Twitter - Image